|
Volumn 44, Issue 9, 2000, Pages 2567-2568
|
In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GEMIFLOXACIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
OFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TROVAFLOXACIN;
TUBERCULOSTATIC AGENT;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACTERIUM ISOLATION;
CONTROLLED STUDY;
CROSS RESISTANCE;
DRUG POTENCY;
HUMAN;
MAJOR CLINICAL STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM TUBERCULOSIS;
PRIORITY JOURNAL;
ANTI-INFECTIVE AGENTS;
ANTITUBERCULAR AGENTS;
DRUG RESISTANCE, MICROBIAL;
FLUOROQUINOLONES;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
MYCOBACTERIUM TUBERCULOSIS;
|
EID: 0033844326
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.44.9.2567-2568.2000 Document Type: Article |
Times cited : (71)
|
References (14)
|